Cargando…

Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy status

AIM/HYPOTHESIS: The glucose-lowering drug metformin has been shown to activate hepatic AMP-activated protein kinase (AMPK), a master kinase regulating cellular energy homeostasis. However, the underlying mechanisms remain controversial and have never been investigated in primary human hepatocytes. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Stephenne, X., Foretz, M., Taleux, N., van der Zon, G. C., Sokal, E., Hue, L., Viollet, B., Guigas, B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3210354/
https://www.ncbi.nlm.nih.gov/pubmed/21947382
http://dx.doi.org/10.1007/s00125-011-2311-5
_version_ 1782215727048032256
author Stephenne, X.
Foretz, M.
Taleux, N.
van der Zon, G. C.
Sokal, E.
Hue, L.
Viollet, B.
Guigas, B.
author_facet Stephenne, X.
Foretz, M.
Taleux, N.
van der Zon, G. C.
Sokal, E.
Hue, L.
Viollet, B.
Guigas, B.
author_sort Stephenne, X.
collection PubMed
description AIM/HYPOTHESIS: The glucose-lowering drug metformin has been shown to activate hepatic AMP-activated protein kinase (AMPK), a master kinase regulating cellular energy homeostasis. However, the underlying mechanisms remain controversial and have never been investigated in primary human hepatocytes. METHODS: Hepatocytes isolated from rat, mouse and human livers were treated with various concentrations of metformin. Isoform-specific AMPKα abundance and activity, as well as intracellular adenine nucleotide levels and mitochondrial oxygen consumption rates were determined at different time points. RESULTS: Metformin dose- and time-dependently increased AMPK activity in rat and human hepatocytes, an effect associated with a significant rise in cellular AMP:ATP ratio. Surprisingly, we found that AMPKα2 activity was undetectable in human compared with rat hepatocytes, while AMPKα1 activities were comparable. Accordingly, metformin only increased AMPKα1 activity in human hepatocytes, although both AMPKα isoforms were activated in rat hepatocytes. Analysis of mRNA expression and protein levels confirmed that only AMPKα1 is present in human hepatocytes; it also showed that the distribution of β and γ regulatory subunits differed between species. Finally, we demonstrated that the increase in AMP:ATP ratio in hepatocytes from liver-specific Ampkα1/2 (also known as Prkaa1/2) knockout mice and humans is due to a similar and specific inhibition of the mitochondrial respiratory-chain complex 1 by metformin. CONCLUSIONS/INTERPRETATION: Activation of hepatic AMPK by metformin results from a decrease in cellular energy status owing to metformin’s AMPK-independent inhibition of the mitochondrial respiratory-chain complex 1. The unique profile of AMPK subunits found in human hepatocytes should be considered when developing new pharmacological agents to target the kinase. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00125-011-2311-5) contains peer-reviewed but unedited supplementary material, which is available to authorised users.
format Online
Article
Text
id pubmed-3210354
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-32103542011-11-28 Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy status Stephenne, X. Foretz, M. Taleux, N. van der Zon, G. C. Sokal, E. Hue, L. Viollet, B. Guigas, B. Diabetologia Article AIM/HYPOTHESIS: The glucose-lowering drug metformin has been shown to activate hepatic AMP-activated protein kinase (AMPK), a master kinase regulating cellular energy homeostasis. However, the underlying mechanisms remain controversial and have never been investigated in primary human hepatocytes. METHODS: Hepatocytes isolated from rat, mouse and human livers were treated with various concentrations of metformin. Isoform-specific AMPKα abundance and activity, as well as intracellular adenine nucleotide levels and mitochondrial oxygen consumption rates were determined at different time points. RESULTS: Metformin dose- and time-dependently increased AMPK activity in rat and human hepatocytes, an effect associated with a significant rise in cellular AMP:ATP ratio. Surprisingly, we found that AMPKα2 activity was undetectable in human compared with rat hepatocytes, while AMPKα1 activities were comparable. Accordingly, metformin only increased AMPKα1 activity in human hepatocytes, although both AMPKα isoforms were activated in rat hepatocytes. Analysis of mRNA expression and protein levels confirmed that only AMPKα1 is present in human hepatocytes; it also showed that the distribution of β and γ regulatory subunits differed between species. Finally, we demonstrated that the increase in AMP:ATP ratio in hepatocytes from liver-specific Ampkα1/2 (also known as Prkaa1/2) knockout mice and humans is due to a similar and specific inhibition of the mitochondrial respiratory-chain complex 1 by metformin. CONCLUSIONS/INTERPRETATION: Activation of hepatic AMPK by metformin results from a decrease in cellular energy status owing to metformin’s AMPK-independent inhibition of the mitochondrial respiratory-chain complex 1. The unique profile of AMPK subunits found in human hepatocytes should be considered when developing new pharmacological agents to target the kinase. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00125-011-2311-5) contains peer-reviewed but unedited supplementary material, which is available to authorised users. Springer-Verlag 2011-09-23 2011 /pmc/articles/PMC3210354/ /pubmed/21947382 http://dx.doi.org/10.1007/s00125-011-2311-5 Text en © The Author(s) 2011 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Article
Stephenne, X.
Foretz, M.
Taleux, N.
van der Zon, G. C.
Sokal, E.
Hue, L.
Viollet, B.
Guigas, B.
Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy status
title Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy status
title_full Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy status
title_fullStr Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy status
title_full_unstemmed Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy status
title_short Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy status
title_sort metformin activates amp-activated protein kinase in primary human hepatocytes by decreasing cellular energy status
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3210354/
https://www.ncbi.nlm.nih.gov/pubmed/21947382
http://dx.doi.org/10.1007/s00125-011-2311-5
work_keys_str_mv AT stephennex metforminactivatesampactivatedproteinkinaseinprimaryhumanhepatocytesbydecreasingcellularenergystatus
AT foretzm metforminactivatesampactivatedproteinkinaseinprimaryhumanhepatocytesbydecreasingcellularenergystatus
AT taleuxn metforminactivatesampactivatedproteinkinaseinprimaryhumanhepatocytesbydecreasingcellularenergystatus
AT vanderzongc metforminactivatesampactivatedproteinkinaseinprimaryhumanhepatocytesbydecreasingcellularenergystatus
AT sokale metforminactivatesampactivatedproteinkinaseinprimaryhumanhepatocytesbydecreasingcellularenergystatus
AT huel metforminactivatesampactivatedproteinkinaseinprimaryhumanhepatocytesbydecreasingcellularenergystatus
AT violletb metforminactivatesampactivatedproteinkinaseinprimaryhumanhepatocytesbydecreasingcellularenergystatus
AT guigasb metforminactivatesampactivatedproteinkinaseinprimaryhumanhepatocytesbydecreasingcellularenergystatus